SCHEMBL4014555

SCHEMBL4014555

O=C(O)N(c1ccccc1)S(=O)(=O)c1ccc(C#CCO)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
MMP2 P08253 3/20 0.41
MMP12 P39900 1/20 0.41
MMP13 P45452 3/20 0.40
ESR1 P03372 4/20 0.40
TAS2R14 Q9NYV8 2/20 0.39
LIMK2 P53671 1/20 0.38
MEN1 O00255 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
PKM P14618 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
MMP3 P08254 1/20 0.37
CA7 P43166 1/20 0.36
FFAR1 O14842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3467601 0.88 KMT2A (0.43) KMT2AMMP2MMP13ESR1TAS2R14
SCHEMBL4014559 0.85 LMNA (0.41) KMT2AMEN1CA12CA1CA2
SCHEMBL1856286 0.83 KMT2A (0.40) KMT2AMMP2MMP12MMP13ESR1
SCHEMBL4015138 0.78 MMP2 (0.44) MMP2MMP12MMP13TAS2R14LIMK2
SCHEMBL10728056 0.74 CA12 (0.62) KMT2ATAS2R14CA12CA9KEAP1
SCHEMBL1856837 0.74 KMT2A (0.53) KMT2AESR1TAS2R14CA12CA9
SCHEMBL4008265 0.74 LMNA (0.41) KMT2AMEN1CA12CA1CA2
SCHEMBL1859337 0.72 ESR1 (0.39) KMT2AMMP2MMP13ESR1MEN1
SCHEMBL20183917 0.72 LMNA (0.56) KMT2AMEN1HTT
SCHEMBL4014515 0.70 PTGDR2 (0.41) KMT2ATAS2R14MEN1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080722-A2 CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-07-02 WO disclosed